Novavax tops Q2 estimates and lifts 2025 sales forecast as Sanofi takes over global rollout of its COVID vaccine.

COVID vaccines, including the new non-mRNA product Novavax, are safe and effective and decrease the burden of illness and ...

The Novavax COVID-19 vaccine is the first protein-based vaccine to be offered in Canada as part of a two-dose regimen of five mcg per dose. These vaccines contain a modified version of the spike ...

Novavax on Wednesday raised its full-year revenue forecast as it received a $175 million milestone payment from Sanofi ...

Novavax beat Wall Street expectations for second-quarter revenue on Wednesday, helped by a $175 million milestone payment ...

We have ongoing trials further exploring the Novavax COVID-19 vaccine's potential as an effective booster against these variants, including BA.4/5, and look forward to sharing these data." ...

Novavax’s COVID-19 shot “is a technology commonly used in most other vaccines, such as flu, hepatitis B and shingles,” said Dr. Mahdee Sobhanie, an infectious diseases physician at Ohio State ...

A worker moves boxes carrying Novavax Inc.'s COVID-19 vaccine, Nuvaxovid, in Andong, South Korea on Feb. 9. South Korea is among several countries who have been administering the vaccine in recent ...

Novavax COVID-19 Vaccine, Adjuvanted (2023-2024 Formula) has not been approved or licensed by FDA, but has been authorized for emergency use by FDA, under an EUA to prevent Coronavirus Disease ...

“Pending Health Canada approval, tens of millions of Novavax COVID-19 doses will be made right here at home.” But no one should expect made-in-Canada doses any time soon.